0001209191-20-004809.txt : 20200124 0001209191-20-004809.hdr.sgml : 20200124 20200124161051 ACCESSION NUMBER: 0001209191-20-004809 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200122 FILED AS OF DATE: 20200124 DATE AS OF CHANGE: 20200124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Parini Michael CENTRAL INDEX KEY: 0001661567 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 20545594 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS, INC. STREET 2: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-01-22 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001661567 Parini Michael C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, CL&AO Common Stock 2020-01-22 4 M 0 1 187.53 A 35004 D Common Stock 2020-01-22 4 S 0 1 237.50 D 35003 D Stock Option (Right to Buy) 187.53 2020-01-22 4 M 0 1 0.00 D 2029-02-05 Common Stock 1 20854 D Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. The option vests in 16 quarterly installments from 02/06/2019. /s/ Omar White, Attorney-in-Fact 2020-01-24